A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.


Updates from The Motley Fool

Latest updates on Arena Pharmaceuticals from Fool.com.


Stock Performance

ARNA vs. S&P 500 | 2 Year Performance
View Interactive ARNA Charts
Sponsored by

Key Data Points

Primary metrics and data points about Arena Pharmaceuticals.
Current Price: $1.67
Prev Close: $1.68
Open: $1.67
Bid: $1.65
Ask: $1.70
Day's Range: $1.66 - $1.70
52wk Range: $1.30 - $4.09
Volume: 737,472
Avg Vol 1,758,937
Market Cap: $405.06M
P/E (ttm): -3.82
EPS (ttm): -$0.44
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Arena Pharmaceuticals.
CAPS Rating 2 out of 5
 
765 Outperform
70 Underperform
CAPS All Stars
 
109 Outperform
14 Underperform

How do you think Arena Pharmaceuticals will perform against the market?



You pick for Arena Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Jackie Lief, CEO

45% Approve

Based on 7 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Arena Pharmaceuticals.

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers